Exhibit 10.2

EXECUTION COPY

9,250,000 Shares

COMMERCIAL VEHICLE GROUP, INC.

Common Stock

UNDERWRITING AGREEMENT

August 4, 2004

Credit Suisse First Boston LLC,
  As Representative of the Several Underwriters,
   NEleven Madison Avenue,
    New York, NY 10010-3629

Dear Sirs:

     1. Introductory. Commercial Vehicle Group, Inc., a Delaware corporation
(“Company”) proposes to issue and sell 3,125,000 shares of its Common Stock, par
value $0.01 per share (“Securities”), and the stockholders listed in Schedule A
hereto (“Selling Stockholders”) propose severally to sell an aggregate of
6,125,000 outstanding shares of the Securities (such 9,250,000 shares of
Securities being hereinafter referred to as the “Firm Securities”), to the
Underwriters (as defined below), for whom Credit Suisse First Boston LLC is
acting as representative (the “Representative”). The Company also proposes to
sell to the Underwriters, at the option of the Underwriters, an aggregate of not
more than 1,387,500 additional shares of its Securities as set forth below (such
1,387,500 additional shares being hereinafter referred to as the "Optional
Securities”). The Firm Securities and the Optional Securities are herein
collectively called the “Offered Securities”. As part of the offering
contemplated by this Agreement, Credit Suisse First Boston LLC (the “Designated
Underwriter") has agreed to reserve out of the Firm Securities purchased by it
under this Agreement, up to 462,500 shares, for sale to the Company’s directors,
officers, employees and other parties associated with the Company (collectively,
“Participants"), as set forth in the Prospectus (as defined herein) under the
heading “Underwriting” (the “Directed Share Program"). The Firm Securities to be
sold by the Designated Underwriter pursuant to the Directed Share Program (the
“Directed Shares") will be sold by the Designated Underwriter pursuant to this
Agreement at the public offering price. Any Directed Shares not subscribed for
by the end of the business day on which this Agreement is executed will be
offered to the public by the Underwriters as set forth in the Prospectus. The
Company and the Selling Stockholders hereby agree with the several Underwriters
named in Schedule B hereto (“Underwriters”) as follows:

 

--------------------------------------------------------------------------------

 

     2. Representations and Warranties of the Company and the Selling
Stockholders. (a) The Company represents and warrants to, and agrees with, the
several Underwriters that:

     (i) A registration statement (No. 333-115708) relating to the Offered
Securities, including a form of prospectus, has been filed with the Securities
and Exchange Commission (“Commission”) and either (A) has been declared
effective under the Securities Act of 1933 (“Act”) and is not proposed to be
amended or (B) is proposed to be amended by amendment or post-effective
amendment. If such registration statement (the “initial registration statement”)
has been declared effective, either (A) an additional registration statement
(the “additional registration statement”) relating to the Offered Securities may
have been filed with the Commission pursuant to Rule 462(b) (“Rule 462(b)”)
under the Act and, if so filed, has become effective upon filing pursuant to
such Rule and the Offered Securities all have been duly registered under the Act
pursuant to the initial registration statement and, if applicable, the
additional registration statement or (B) such an additional registration
statement is proposed to be filed with the Commission pursuant to Rule 462(b)
and will become effective upon filing pursuant to such Rule and upon such filing
the Offered Securities will all have been duly registered under the Act pursuant
to the initial registration statement and such additional registration
statement. If the Company does not propose to amend the initial registration
statement or if an additional registration statement has been filed and the
Company does not propose to amend it, and if any post-effective amendment to
either such registration statement has been filed with the Commission prior to
the execution and delivery of this Agreement, the most recent amendment (if any)
to each such registration statement has been declared effective by the
Commission or has become effective upon filing pursuant to Rule 462(c) (“Rule
462(c)”) under the Act or, in the case of the additional registration statement,
Rule 462(b). For purposes of this Agreement, “Effective Time” with respect to
the initial registration statement or, if filed prior to the execution and
delivery of this Agreement, the additional registration statement means (A) if
the Company has advised the Representative that it does not propose to amend
such registration statement, the date and time as of which such registration
statement, or the most recent post-effective amendment thereto (if any) filed
prior to the execution and delivery of this Agreement, was declared effective by
the Commission or has become effective upon filing pursuant to Rule 462(c), or
(B) if the Company has advised the Representative that it proposes to file an
amendment or post-effective amendment to such registration statement, the date
and time as of which such registration statement, as amended by such amendment
or post-effective amendment, as the case may be, is declared effective by the
Commission. If an additional registration statement has not been filed prior to
the execution and delivery of this Agreement but the Company has advised the
Representative that it proposes to file one, “Effective Time” with respect to
such additional registration statement means the date and time as of which such
registration statement is filed and becomes effective pursuant to Rule 462(b).
“Effective Date” with respect to the initial registration statement or the
additional registration statement (if any) means the date of the Effective Time
thereof. The initial registration statement, as amended at its Effective Time,
including all information contained in the additional registration statement (if
any) and deemed to be a part of the initial registration statement as of the
Effective Time of the additional registration statement pursuant to the General
Instructions of the Form on which it is filed and including all information (if
any) deemed to be a part of the initial registration statement as of its
Effective Time pursuant to Rule 430A(b) (“Rule 430A(b)”) under the Act, is
hereinafter referred to as the “Initial Registration Statement”. The additional
registration statement, as amended at its Effective Time,

2

--------------------------------------------------------------------------------

 

including the contents of the initial registration statement incorporated by
reference therein and including all information (if any) deemed to be a part of
the additional registration statement as of its Effective Time pursuant to
Rule 430A(b), is hereinafter referred to as the “Additional Registration
Statement”. The Initial Registration Statement and the Additional Registration
Statement are hereinafter referred to collectively as the “Registration
Statements” and individually as a “Registration Statement”. The form of
prospectus relating to the Offered Securities, as first filed with the
Commission pursuant to and in accordance with Rule 424(b) (“Rule 424(b)”) under
the Act or (if no such filing is required) as included in a Registration
Statement, is hereinafter referred to as the “Prospectus”. No document has been
or will be prepared or distributed in reliance on Rule 434 under the Act.

     (ii) If the Effective Time of the Initial Registration Statement is prior
to the execution and delivery of this Agreement: (A) on the Effective Date of
the Initial Registration Statement, the Initial Registration Statement conformed
in all material respects to the requirements of the Act and the rules and
regulations of the Commission (“Rules and Regulations”) and did not include any
untrue statement of a material fact or omit to state any material fact required
to be stated therein or necessary to make the statements therein not misleading,
(B) on the Effective Date of the Additional Registration Statement (if any),
each Registration Statement conformed or will conform, in all material respects
to the requirements of the Act and the Rules and Regulations and did not
include, or will not include, any untrue statement of a material fact and did
not omit, or will not omit, to state any material fact required to be stated
therein or necessary to make the statements therein not misleading, and (C) on
the date of this Agreement, the Initial Registration Statement and, if the
Effective Time of the Additional Registration Statement is prior to the
execution and delivery of this Agreement, the Additional Registration Statement
each conforms, and at the time of filing of the Prospectus pursuant to Rule
424(b) or (if no such filing is required) at the Effective Date of the
Additional Registration Statement in which the Prospectus is included, each
Registration Statement and the Prospectus will conform, in all material respects
to the requirements of the Act and the Rules and Regulations, and neither of
such documents includes, or will include, any untrue statement of a material
fact or omits, or will omit, to state any material fact required to be stated
therein or necessary to make the statements therein not misleading. If the
Effective Time of the Initial Registration Statement is subsequent to the
execution and delivery of this Agreement: on the Effective Date of the Initial
Registration Statement, the Initial Registration Statement and the Prospectus
will conform in all material respects to the requirements of the Act and the
Rules and Regulations, neither of such documents will include any untrue
statement of a material fact or will omit to state any material fact required to
be stated therein or necessary to make the statements therein not misleading,
and no Additional Registration Statement has been or will be filed. The two
preceding sentences do not apply to statements in or omissions from a
Registration Statement or the Prospectus based upon written information
furnished to the Company by any Underwriter through the Representative
specifically for use therein, it being understood and agreed that the only such
information is that described as such in Section 7(c) hereof, or relating to the
Selling Stockholders, furnished in writing to the Company by a Selling
Stockholder specifically for use therein.

3

--------------------------------------------------------------------------------

 

     (iii) The Company has been duly incorporated and is an existing corporation
in good standing under the laws of the State of Delaware, with power and
authority (corporate and other) to own its properties and conduct its business
as described in the Prospectus; and the Company is duly qualified to do business
as a foreign corporation in good standing in all other jurisdictions in which
its ownership or lease of property or the conduct of its business requires such
qualification, except where the failure to be so qualified would not have a
material adverse effect on the condition (financial or other), business,
properties or results of operations of the Company and its subsidiaries, taken
as a whole (a “Material Adverse Effect”).

     (iv) Each subsidiary of the Company has been duly incorporated and is an
existing corporation in good standing under the laws of the jurisdiction of its
incorporation, with corporate power and authority to own or lease its properties
and conduct its business as described in the Prospectus; and each subsidiary of
the Company is duly qualified to do business as a foreign corporation in good
standing in all other jurisdictions in which its ownership or lease of property
or the conduct of its business requires such qualification, except where the
failure to be so qualified would not have a Material Adverse Effect; all of the
issued and outstanding capital stock of each subsidiary of the Company has been
duly authorized and validly issued and is fully paid and nonassessable; and the
capital stock of each subsidiary owned by the Company, directly or through
subsidiaries, is owned free from liens, encumbrances and defects (other than
transfer restrictions imposed under applicable securities laws).

     (v) The entities listed on Schedule C hereto are the only subsidiaries of
the Company.

     (vi) No subsidiary, other than the subsidiaries indicated as “significant
subsidiaries” on Schedule C hereto, as of December 31, 2003, was a “significant
subsidiary” within the meaning of Regulation S-X under the Act.

     (vii) The Offered Securities and all other outstanding shares of capital
stock of the Company have been duly authorized and validly issued, fully paid
and nonassessable and conform in all material respects to the description
thereof contained in the Prospectus; and the stockholders of the Company have no
preemptive rights with respect to the Securities.

     (viii) Except as disclosed in the Prospectus, there are no contracts,
agreements or understandings between the Company and any person that would give
rise to a valid claim against the Company or any Underwriter for a brokerage
commission, finder’s fee or other like payment in connection with this offering.

     (ix) There are no contracts, agreements or understandings between the
Company and any person granting such person the right to require the Company to
file a registration statement under the Act with respect to any securities of
the Company owned or to be owned by such person or to require the Company to
include such securities in the securities registered pursuant to a Registration
Statement or in any securities being

4

--------------------------------------------------------------------------------

 

registered pursuant to any other registration statement filed by the Company
under the Act that have not otherwise been complied with or waived.

     (x) The Securities have been approved for listing, subject to notice of
issuance, on The Nasdaq National Market.

     (xi) No consent, approval, authorization, or order of, or filing with, any
governmental agency or body or any court is required to be obtained or made by
the Company for the consummation of the transactions contemplated by this
Agreement in connection with the sale of the Offered Securities, except such as
have been obtained and made under the Act and the Securities Exchange Act of
1934 (the “Exchange Act”), and such as may be required under state securities
laws or rules of the National Association of Securities Dealers, Inc. (the
“NASD”).

     (xii) The execution, delivery and performance of this Agreement, and the
consummation of the transactions herein contemplated will not result in a breach
or violation of any of the terms and provisions of, or constitute a default
under, (a) any statute, any rule, regulation or order of any governmental agency
or body or any court, domestic or foreign, having jurisdiction over the Company
or any subsidiary of the Company or any of their properties, or (b) any
agreement or instrument to which the Company or any such subsidiary is a party
or by which the Company or any such subsidiary is bound or to which any of the
properties of the Company or any such subsidiary is subject, or (c) the charter
or by-laws of the Company or any such subsidiary, other than, in the case of
(a) and (b), conflicts or breaches that, individually or in the aggregate, would
not reasonably be expected to have a Material Adverse Effect.

     (xiii) This Agreement has been duly authorized, executed and delivered by
the Company.

     (xiv) Except as disclosed in the Prospectus, the Company and its
subsidiaries have good and marketable title to all real properties and all other
properties and assets owned by them, in each case free from liens, encumbrances
and defects the enforcement of which would reasonably be expected to have a
Material Adverse Effect; and except as disclosed in the Prospectus, the Company
and its subsidiaries hold any leased real or personal property under valid and
enforceable leases with no exceptions that would materially interfere with the
use made or to be made thereof by them and no material default has occurred or
is continuing under any material lease to which the Company or any of its
subsidiaries is a party.

     (xv) The Company and its subsidiaries possess adequate certificates,
authorizations or permits issued by appropriate governmental agencies or bodies
necessary to conduct the business now operated by them, except for such
certificates, authorizations or permits the absence of which, individually or in
the aggregate, would not have a Material Adverse Effect and have not received
any notice of proceedings relating to the revocation or modification of any such
certificate, authorization or permit that, if determined adversely to the
Company or any of its subsidiaries, would individually or in the aggregate have
a Material Adverse Effect.

5

--------------------------------------------------------------------------------

 

     (xvi) No labor dispute with the employees of the Company or any subsidiary
exists or, to the knowledge of the Company, is imminent that would reasonably be
expected to have a Material Adverse Effect.

     (xvii) The Company and its subsidiaries own, possess or can acquire on
reasonable terms, adequate trademarks, trade names and other rights to
inventions, know-how, patents, copyrights, confidential information and other
intellectual property (collectively, “intellectual property rights”) necessary
to conduct the business now operated by them, or presently employed by them, and
have not received any notice of infringement of or conflict with asserted rights
of others with respect to any intellectual property rights that, if determined
adversely to the Company or any of its subsidiaries, which individually or in
the aggregate would reasonably be expected to have a Material Adverse Effect.

     (xviii) Except as disclosed in the Prospectus, neither the Company nor any
of its subsidiaries is in violation of any statute, any rule, regulation,
decision or order of any governmental agency or body or any court, domestic or
foreign, relating to the use, disposal or release of hazardous or toxic
substances or relating to the protection or restoration of the environment or
human exposure to hazardous or toxic substances (collectively, “environmental
laws”), owns or operates any real property contaminated with any substance that
is subject to any environmental laws, is liable for any off-site disposal or
contamination pursuant to any environmental laws, or is subject to any claim
relating to any environmental laws, which violation, contamination, liability or
claim would individually or in the aggregate have a Material Adverse Effect; and
the Company is not aware of any pending investigation which might lead to such a
claim.

     (xix) Except as disclosed in the Prospectus, there are no pending actions,
suits or proceedings against or affecting the Company, any of its subsidiaries
or any of their respective properties that, if determined adversely to the
Company or any of its subsidiaries, would individually or in the aggregate have
a Material Adverse Effect, or would materially and adversely affect the ability
of the Company to perform its obligations under this Agreement, or which are
otherwise material in the context of the sale of the Offered Securities; and, to
the Company’s knowledge, no such actions, suits or proceedings are threatened or
contemplated.

     (xx) The financial statements, together with related notes, included in
each Registration Statement and the Prospectus present fairly in all material
respects the financial position of the Company and its consolidated subsidiaries
as of the dates shown and their results of operations and cash flows for the
periods shown, and such financial statements have been prepared in accordance
with the generally accepted accounting principles in the United States applied
on a consistent basis; and the schedules included in each Registration Statement
present fairly the information required to be stated therein.

     (xxi) Each of the Company and its consolidated subsidiaries maintain a
system of internal accounting controls sufficient to provide reasonable
assurance that (a) transactions are executed in accordance with management’s
general or specific

6

--------------------------------------------------------------------------------

 

authorizations; (b) transactions are recorded as necessary to permit preparation
of financial statements in conformity with generally accepted accounting
principles and to maintain asset accountability; (c) access to assets is
permitted only in accordance with management’s general or specific
authorization; and (d) the recorded accountability for assets is compared with
the existing assets at reasonable intervals and appropriate action is taken with
respect to any differences.

     (xxii) Except as disclosed in the Prospectus, since the date of the latest
audited financial statements included in the Prospectus there has been no
material adverse change, nor any development or event involving a prospective
material adverse change, in the condition (financial or other), business,
properties or results of operations of the Company and its subsidiaries taken as
a whole, and, except as disclosed in or contemplated by the Prospectus, there
has been no dividend or distribution of any kind declared, paid or made by the
Company on any class of its capital stock.

     (xxiii) The Company is not and, after giving effect to the offering and
sale of the Offered Securities and the application of the proceeds thereof as
described in the Prospectus, will not be an “investment company” as defined in
the Investment Company Act of 1940, as amended.

     (xxiv) The Company has not taken, directly or indirectly, any action
designed to or that would constitute or that might reasonably be expected to
cause or result in, under the Exchange Act or otherwise, stabilization or
manipulation of the price of any security of the Company to facilitate the sale
or resale of the Securities.

     (xxv) Except as would not, individually or in the aggregate, reasonably be
expected to have a Material Adverse Effect, (A) The minimum funding standard
under Section 302 of the Employee Retirement Income Security Act of 1974, as
amended, and the regulations and published interpretations thereunder (“ERISA”),
has been satisfied by each “pension plan” (as defined in Section 3(2) of ERISA)
which has been established or maintained by the Company and/or one or more of
its subsidiaries, each plan which is intended to be qualified under Section 401
of the Code is so qualified; (B) each of the Company and its subsidiaries has
fulfilled its obligations, if any, under Section 515 of ERISA; (C) neither the
Company nor any of its subsidiaries maintains or is required to contribute to a
“welfare plan” (as defined in Section 3(1) of ERISA) which provides retiree or
other post-employment welfare benefits or insurance coverage (other than
“continuation coverage” (as defined in Section 602 of ERISA)); (D) each pension
plan and welfare plan established or maintained by the Company and/or one or
more of its subsidiaries is in compliance with the currently applicable
provisions of ERISA and the Code; and (E) neither the Company nor any of its
subsidiaries has incurred or could reasonably be expected to incur any
withdrawal liability under Section 4201 of ERISA, any liability under
Section 4062, 4063, or 4064 of ERISA, or any other liability under Title IV of
ERISA.

     (xxvi) There is and has been no failure on the part of the Company and any
of the Company’s directors or officers, in their capacities as such, to comply
with any provision of the Sarbanes-Oxley Act of 2002 and the rules and
regulations promulgated

7

--------------------------------------------------------------------------------

 

in connection therewith (the “Sarbanes-Oxley Act”), including Section 402
related to loans and Sections 302 and 906 related to certifications, to the
extent such sections are applicable.

     (xxvii) Furthermore, the Company represents and warrants to the
Underwriters that (i) the Registration Statement, the Prospectus and any
preliminary prospectus comply in all material respects, and any further
amendments or supplements thereto will comply in all material respects, with any
applicable laws or regulations of foreign jurisdictions in which the Prospectus
or any preliminary prospectus, as amended or supplemented, if applicable, are
distributed in connection with the Directed Share Program, and that (ii) no
authorization, approval, consent, license, order, registration or qualification
of or with any government, governmental instrumentality or court, other than
such as have been obtained, is necessary under the securities law and
regulations of foreign jurisdictions in which the Directed Shares are offered
outside the United States.

     (xxviii) The Company has not offered, or caused the Underwriters to offer,
any Offered Securities to any person pursuant to the Directed Share Program with
the specific intent to unlawfully influence (i) a customer or supplier of the
Company to alter the customer’s or supplier’s level or type of business with the
Company or (ii) a trade journalist or publication to write or publish favorable
information about the Company or its products.

     (b) Each Selling Stockholder severally represents and warrants to, and
agrees with, the several Underwriters that:

     (i) Such Selling Stockholder has and on each Closing Date hereinafter
mentioned will have valid and unencumbered title to the Offered Securities to be
delivered by such Selling Stockholder on such Closing Date and full right, power
and authority to enter into this Agreement and to sell, assign, transfer and
deliver the Offered Securities to be delivered by such Selling Stockholder on
such Closing Date hereunder; and upon the delivery of and payment for the
Offered Securities to be sold by such Selling Stockholder on each Closing Date
hereunder the several Underwriters will acquire valid and unencumbered title to
the Offered Securities to be delivered by such Selling Stockholder on such
Closing Date.

     (ii) Such Selling Stockholder has not taken, directly or indirectly, any
action designed to or that would constitute or that might reasonably be expected
to cause or result in, under the Exchange Act or otherwise, stabilization or
manipulation of the price of any security of the Company to facilitate the sale
or resale of the Securities.

     (iii) No consent, approval, authorization or order of, or filing with, any
governmental agency or body or any court is required to be obtained or made by
such Selling Stockholder for the consummation of the transactions contemplated
by this Agreement in connection with the sale of the Offered Securities sold by
such Selling Stockholder, except such as have been obtained and made under the
Act and the Exchange Act and such as may be required under state securities laws
or the rules of the NASD.

8

--------------------------------------------------------------------------------

 

     (iv) This Agreement has been duly authorized, executed and delivered by or
on behalf of such Selling Stockholder.

     (v) If the Effective Time of the Initial Registration Statement is prior to
the execution and delivery of this Agreement: (A) on the Effective Date of the
Initial Registration Statement, the Initial Registration Statement did not
include any untrue statement of a material fact or omit to state any material
fact required to be stated therein or necessary to make the statements therein
not misleading, (B) on the Effective Date of the Additional Registration
Statement (if any), each Registration Statement did not include, or will not
include, any untrue statement of a material fact and did not omit, or will not
omit, to state any material fact required to be stated therein or necessary to
make the statements therein not misleading, and (C) on the date of this
Agreement, the Initial Registration Statement and, if the Effective Time of the
Additional Registration Statement is prior to the execution and delivery of this
Agreement, the Additional Registration Statement, and at the time of filing of
the Prospectus pursuant to Rule 424(b) or (if no such filing is required) at the
Effective Date of the Additional Registration Statement in which the Prospectus
is included, each Registration Statement and the Prospectus did not include, or
will not include, any untrue statement of a material fact or omits, or will
omit, to state any material fact required to be stated therein or necessary to
make the statements therein not misleading. If the Effective Time of the Initial
Registration Statement is subsequent to the execution and delivery of this
Agreement: on the Effective Date of the Initial Registration Statement, the
Initial Registration Statement and the Prospectus will not include any untrue
statement of a material fact or will omit to state any material fact required to
be stated therein or necessary to make the statements therein not misleading.
This paragraph 2(b)(v) applies only to statements in or omissions from a
Registration Statement or the Prospectus that relate to such Selling Stockholder
and are based upon written information furnished to the Company by such Selling
Stockholder specifically for use therein.

     (vi) The sale of the Offered Securities by such Selling Stockholder
pursuant hereto is not prompted by any information concerning the Company or any
of its subsidiaries which is not set forth in the Prospectus or any supplement
thereto.

     (vii) Except as disclosed in the Prospectus, there are no contracts,
agreements or understandings between such Selling Stockholder and any person
that would give rise to a valid claim against such Selling Stockholder or any
Underwriter for a brokerage commission, finder’s fee or other like payment in
connection with this offering.

     3. Purchase, Sale and Delivery of Offered Securities. On the basis of the
representations, warranties and agreements herein contained, but subject to the
terms and conditions herein set forth, the Company and each Selling Stockholder
agree, severally and not jointly, to sell to each Underwriter, and each
Underwriter agrees, severally and not jointly, to purchase from the Company and
each Selling Stockholder, at a purchase price of $12.1225 per share, that number
of Firm Securities (rounded up or down, as determined by Credit Suisse First
Boston LLC (“CSFB”) in its discretion, in order to avoid fractions) obtained by
multiplying 3,125,000 Firm Securities in the case of the Company and the number
of Firm Securities set forth opposite the name of such Selling Stockholder in
Schedule A hereto, in the case of a Selling Stockholder, in each case by a
fraction

9

--------------------------------------------------------------------------------

 

the numerator of which is the number of Firm Securities set forth opposite the
name of such Underwriter in Schedule B hereto and the denominator of which is
the total number of Firm Securities.

     Certificates in negotiable form for the Offered Securities to be sold by
the Selling Stockholders listed on Schedule D-1 (the “Custodial Selling
Stockholders”) hereunder have been placed in custody, for delivery under this
Agreement, under Custody Agreements (the “Custody Agreements”) made with Hidden
Creek Industries, as custodian (“Custodian”). The Selling Stockholders other
than the Custodial Selling Stockholders (the “Onex Selling Stockholders”) have
entered into an irrevocable power of attorney appointing Onex American Holdings
II LLC as attorney-in-fact for each Onex Selling Stockholder, with full power
and authority to act in the name of and for and on behalf of each such Onex
Selling Stockholder with respect to all matters arising in connection with the
sale of Securities by each such Onex Selling Stockholder.

     Each Custodial Selling Stockholder agrees that the shares represented by
the certificates held in custody for the Custodial Selling Stockholders under
such Custody Agreements are subject to the interests of the Underwriters
hereunder, that the arrangements made by the Custodial Selling Stockholders for
such custody are to that extent irrevocable, and that the obligations of the
Custodial Selling Stockholders hereunder shall not be terminated by operation of
law, whether by the death of any individual Custodial Selling Stockholder or the
occurrence of any other event, or in the case of a trust, by the death of any
trustee or trustees or the termination of such trust. If any individual
Custodial Selling Stockholder or any such trustee or trustees should die, or if
any other such event should occur, or if any of such trusts should terminate,
before the delivery of the Offered Securities hereunder, certificates for such
Offered Securities shall be delivered by the Custodian in accordance with the
terms and conditions of this Agreement as if such death or other event or
termination had not occurred, regardless of whether or not the Custodian shall
have received notice of such death or other event or termination.

     The Company, the Custodian and the Onex Selling Stockholders will deliver
the Firm Securities to the Representative for the accounts of the Underwriters,
against payment of the purchase price in Federal (same day) funds by official
bank check or checks or wire transfer to an account at a bank acceptable to CSFB
drawn to the order of the Company in the case of 3,125,000 shares of Firm
Securities, the Custodian in the case of 2,300,297 shares of Firm Securities and
Onex American Holdings II LLC in the case of 3,824,703 shares of Firm
Securities, at the office of Cravath, Swaine & Moore LLP, at 10:00 A.M., New
York time, on August 10, 2004, or at such other time not later than seven full
business days thereafter as CSFB and the Company determine, such time being
herein referred to as the “First Closing Date”. For purposes of Rule 15c6-1
under the Exchange Act, the First Closing Date (if later than the otherwise
applicable settlement date) shall be the settlement date for payment of funds
and delivery of securities for all the Offered Securities sold pursuant to the
offering. The certificates for the Firm Securities so to be delivered will be in
definitive form, in such denominations and registered in such names as CSFB
requests and will be made available for checking and packaging at the office of
Cravath, Swaine & Moore LLP at least 24 hours prior to the First Closing Date.

     In addition, upon written notice from CSFB given to the Company from time
to time (not to exceed three times) not more than 30 days subsequent to the date
of the Prospectus, the Underwriters may purchase all or less than all of the
Optional Securities at the purchase price per

10

--------------------------------------------------------------------------------

 

Security to be paid for the Firm Securities. The Company agrees to sell to the
Underwriters the number of Optional Securities specified in such notice and the
Underwriters agree, severally and not jointly, to purchase such Optional
Securities. Such Optional Securities shall be purchased from the Company for the
account of each Underwriter in the same proportion as the number of Firm
Securities set forth opposite such Underwriter’s name bears to the total number
of Firm Securities (subject to adjustment by CSFB to eliminate fractions) and
may be purchased by the Underwriters only for the purpose of covering
over-allotments made in connection with the sale of the Firm Securities. No
Optional Securities shall be sold or delivered unless the Firm Securities
previously have been, or simultaneously are, sold and delivered. The right to
purchase the Optional Securities or any portion thereof may be exercised from
time to time (not to exceed three times) and to the extent not previously
exercised may be surrendered and terminated at any time upon notice by CSFB to
the Company and the Selling Stockholders.

     Each time for the delivery of and payment for the Optional Securities,
being herein referred to as an “Optional Closing Date”, which may be the First
Closing Date (the First Closing Date and each Optional Closing Date, if any,
being sometimes referred to as a “Closing Date”), shall be determined by CSFB
but shall be not later than five full business days after written notice of
election to purchase Optional Securities is given. The Company will deliver the
Optional Securities being purchased from the Company on each Optional Closing
Date to the Representative for the accounts of the several Underwriters, against
payment of the purchase price therefor in Federal (same day) funds by official
bank check or checks or wire transfer to an account at a bank acceptable to CSFB
drawn to the order of the Company with respect to the Optional Securities being
so purchased on such Optional Closing Date, at the office of Cravath, Swaine &
Moore LLP. The certificates for the Optional Securities being purchased on each
Optional Closing Date will be in definitive form, in such denominations and
registered in such names as CSFB requests upon reasonable notice prior to such
Optional Closing Date and will be made available for checking and packaging at
the office of Cravath, Swaine & Moore LLP at a reasonable time in advance of
such Optional Closing Date.

     4. Offering by Underwriters. It is understood that the several Underwriters
propose to offer the Offered Securities for sale to the public as set forth in
the Prospectus.

     5. Certain Agreements of the Company and the Selling Stockholders. The
Company agrees with the several Underwriters and the Selling Stockholders that:

     (a) If the Effective Time of the Initial Registration Statement is prior to
the execution and delivery of this Agreement, the Company will file the
Prospectus with the Commission pursuant to and in accordance with subparagraph
(1) (or, if applicable and if consented to by CSFB, subparagraph (4)) of Rule
424(b) not later than the earlier of (A) the second business day following the
execution and delivery of this Agreement or (B) the fifteenth business day after
the Effective Date of the Initial Registration Statement.

     The Company will advise CSFB promptly of any such filing pursuant to Rule
424(b). If the Effective Time of the Initial Registration Statement is prior to
the execution and delivery of this Agreement and an additional registration
statement is necessary to register a portion of the Offered Securities under the
Act but the Effective Time thereof has not occurred as of such execution and
delivery, the Company will file the additional registration statement or, if
filed, will file a post-

11

--------------------------------------------------------------------------------

 

effective amendment thereto with the Commission pursuant to and in accordance
with Rule 462(b) on or prior to 10:00 P.M., New York time, on the date of this
Agreement or, if earlier, on or prior to the time the Prospectus is printed and
distributed to any Underwriter, or will make such filing at such later date as
shall have been consented to by CSFB.

     (b) The Company will advise CSFB promptly of any proposal to amend or
supplement the initial or any additional registration statement as filed or the
related prospectus or the Initial Registration Statement, the Additional
Registration Statement (if any) or the Prospectus and will not effect such
amendment or supplementation without CSFB’s consent; and the Company will also
advise CSFB promptly of the effectiveness of each Registration Statement (if its
Effective Time is subsequent to the execution and delivery of this Agreement)
and of any amendment or supplementation of a Registration Statement or the
Prospectus and of the institution by the Commission of any stop order
proceedings in respect of a Registration Statement and will use its reasonable
best efforts to prevent the issuance of any such stop order and to obtain as
soon as possible its lifting, if issued.

     (c) If, at any time when a prospectus relating to the Offered Securities is
required to be delivered under the Act in connection with sales by any
Underwriter or dealer, any event occurs as a result of which the Prospectus as
then amended or supplemented would include an untrue statement of a material
fact or omit to state any material fact necessary to make the statements
therein, in the light of the circumstances under which they were made, not
misleading, or if it is necessary at any time to amend the Prospectus to comply
with the Act, the Company will promptly notify CSFB of such event and will
promptly prepare and file with the Commission, at its own expense, an amendment
or supplement which will correct such statement or omission or an amendment
which will effect such compliance. Neither CSFB’s consent to, nor the
Underwriters’ delivery of, any such amendment or supplement shall constitute a
waiver of any of the conditions set forth in Section 6.

     (d) As soon as practicable, but not later than the Availability Date (as
defined below), the Company will make generally available to its securityholders
an earnings statement covering a period of at least 12 months beginning after
the Effective Date of the Initial Registration Statement (or, if later, the
Effective Date of the Additional Registration Statement) which will satisfy the
provisions of Section 11(a) of the Act. For the purpose of the preceding
sentence, “Availability Date” means the 45th day after the end of the fourth
fiscal quarter following the fiscal quarter that includes such Effective Date,
except that, if such fourth fiscal quarter is the last quarter of the Company’s
fiscal year, “Availability Date” means the 90th day after the end of such fourth
fiscal quarter.

     (e) The Company will furnish to the Representative copies of each
Registration Statement (four of which will be signed and one of which will
include all exhibits), each related preliminary prospectus, and, so long as a
prospectus relating to the Offered Securities is required to be delivered under
the Act in connection with sales by any Underwriter or dealer, the Prospectus
and all amendments and supplements to such documents, in each case in such
quantities as CSFB reasonably requests. The Prospectus shall be so furnished on
or prior to 3:00 P.M., New York time, on the business day following the later of
the execution and delivery of this Agreement or the Effective Time of the
Initial Registration Statement. All other such

12

--------------------------------------------------------------------------------

 

documents shall be so furnished as soon as available. The Company and the
Selling Stockholders will pay the expenses of printing and distributing to the
Underwriters all such documents.

     (f) The Company will arrange for the qualification of the Offered
Securities for sale under the laws of such jurisdictions as CSFB designates and
will continue such qualifications in effect so long as required for the
distribution; provided, however, that the Company shall not be required to
qualify to do business, consent to service of process or become subject to
taxation in any jurisdiction in which it has not already done so.

     (g) During the period of three years hereafter, the Company will furnish to
the Representative and, upon request, to each of the other Underwriters, as soon
as practicable after the end of each fiscal year, a copy of its annual report to
stockholders for such year; and the Company will furnish to the Representative
(i) as soon as available, a copy of each report and any definitive proxy
statement of the Company filed with the Commission under the Exchange Act or
mailed to stockholders, and (ii) from time to time, such other information
concerning the Company as CSFB may reasonably request.

     (h) For the period specified below (the “Lock-Up Period”), the Company will
not offer, sell, contract to sell, pledge or otherwise dispose of, directly or
indirectly, or file with the Commission a registration statement under the Act
relating to, any additional shares of its Securities or securities convertible
into or exchangeable or exercisable for any shares of its Securities, or
publicly disclose the intention to make any such offer, sale, pledge,
disposition or filing, without the prior written consent of CSFB. The initial
Lock-Up Period will commence on the date of this Agreement and continue for
180 days after the public offering date set forth on the final prospectus used
to sell the Securities (the “Public Offering Date”) or such earlier date that
CSFB consents to in writing; provided, however, that if (1) during the last
17 days of the initial Lock-Up Period, the Company releases earnings results or
material news or a material event relating to the Company occurs or (2) prior to
the expiration of the initial Lock-Up Period, the Company announces that it will
release earnings results during the 16-day period beginning on the last day of
the initial Lock-Up Period, then in each case, the Lock-Up Period will be
extended until the expiration of the 18-day period beginning on the date of
release of the earnings results or the occurrence of the material news or
material event, as applicable, unless CSFB waives, in writing, such extension.
Any Securities received upon exercise of options granted to the undersigned will
also be subject to this paragraph 5(h). Any Securities acquired in the open
market or in the Directed Share Program, and any Securities sold in the Offering
pursuant to this Agreement, will not be subject to this paragraph 5(h). A
transfer of Securities to a family member, trust or controlled affiliate may be
made, provided the transferee agrees to be bound in writing by the terms of this
paragraph 5(h). In addition, the Company may transfer Securities or securities
convertible into or exchangeable or exercisable for Securities pursuant to a
sale of 100% of the outstanding Securities (including, without limitation, in
connection with a tender offer for such Securities or by way of merger of the
Company with another person) to a third party or group of third parties that are
not affiliates of the Company, provided that the third party or group of third
parties agrees in writing to be bound by the restrictions set forth herein until
such time as such third party or group of third parties has acquired 100% of the
outstanding Securities of the Company.

13

--------------------------------------------------------------------------------

 

     (i) The Company and each Selling Stockholder agree with the several
Underwriters that the Company and such Selling Stockholder will pay all expenses
incident to the performance of the obligations of the Company and such Selling
Stockholder, as the case may be, under this Agreement; the Company will pay for
any filing fees and other expenses (including fees and disbursements of counsel)
in connection with qualification of the Offered Securities for sale under the
laws of such jurisdictions as CSFB designates and the printing of memoranda
relating thereto, for the filing fee incident to the review by the NASD of the
Offered Securities, for any travel expenses of the Company’s officers and
employees and any other expenses of the Company in connection with attending or
hosting meetings with prospective purchasers of the Offered Securities and for
expenses incurred in distributing preliminary prospectuses and the Prospectus
(including any amendments and supplements thereto) to the Underwriters and each
Selling Stockholder will pay for any transfer taxes on the sale by such Selling
Stockholder of the Offered Securities to the Underwriters. Nothing in this
paragraph 5(i) amends or otherwise alters any existing agreement among the
Company and the Selling Stockholders with respect to responsibilities for
expenses in connection with the registration of the Offered Securities.

     (j) In connection with the Directed Share Program, the Company will ensure
that the Directed Shares will be restricted to the extent required by the NASD
or the NASD rules from sale, transfer, assignment, pledge or hypothecation for a
period of three months following the date of the effectiveness of the
Registration Statement. The Designated Underwriter will notify the Company as to
which Participants will need to be so restricted. The Company will direct the
transfer agent to place stop transfer restrictions upon such securities for such
period of time.

     (k) The Company will pay all fees and disbursements of counsel incurred by
the Underwriters in connection with the Directed Share Program and stamp duties,
similar taxes or duties or other taxes, if any, incurred by the underwriters in
connection with the Directed Share Program.

     Furthermore, the Company covenants with the Underwriters that the Company
will comply with all applicable securities and other applicable laws, rules and
regulations in each foreign jurisdiction in which the Directed Shares are
offered in connection with the Directed Share Program.

     6. Conditions of the Obligations of the Underwriters. The obligations of
the several Underwriters to purchase and pay for the Firm Securities on the
First Closing Date and the Optional Securities to be purchased on each Optional
Closing Date will be subject to the accuracy of the representations and
warranties on the part of the Company and the Selling Stockholders herein, to
the accuracy in all material respects of the statements of Company officers made
pursuant to the provisions hereof, to the performance in all material respects
by the Company and the Selling Stockholders of their obligations hereunder and
to the following additional conditions precedent:

     (a) The Representative shall have received a letter, dated the date of
delivery thereof (which, if the Effective Time of the Initial Registration
Statement is prior to the execution and delivery of this Agreement, shall be on
or prior to the date of this Agreement or, if the Effective Time of the Initial
Registration Statement is subsequent to the execution and delivery of this
Agreement, shall be prior to the filing of the amendment or post-effective
amendment to the registration statement to be filed shortly prior to such
Effective Time), of Deloitte & Touche LLP

14

--------------------------------------------------------------------------------

 

confirming that they are independent certified public accountants within the
meaning of the Act and the applicable published Rules and Regulations thereunder
and stating to the effect that:

     (i) in their opinion the financial statements and schedules examined by
them and included in the Registration Statements comply as to form in all
material respects with the applicable accounting requirements of the Act and the
related published Rules and Regulations;

     (ii) they have performed the procedures specified by the American Institute
of Certified Public Accountants for a review of interim financial information as
described in Statement of Auditing Standards No. 100, Interim Financial
Information, on the unaudited financial statements included in the Registration
Statements;

     (iii) on the basis of the review referred to in clause (ii) above, a
reading of the latest available interim financial statements of the Company,
inquiries of officials of the Company who have responsibility for financial and
accounting matters and other specified procedures, nothing came to their
attention that caused them to believe that:

     (A) the unaudited financial statements included in the Registration
Statements do not comply as to form in all material respects with the applicable
accounting requirements of the Act and the related published Rules and
Regulations or any material modifications should be made to such unaudited
financial statements for them to be in conformity with generally accepted
accounting principles;

     (B) at the date of the latest available balance sheet read by such
accountants, or at a subsequent specified date not more than three business days
prior to the date of this Agreement, there was any change in the capital stock
or any increase in total debt of the Company and its consolidated subsidiaries
or, at the date of the latest available balance sheet read by such accountants,
there was any decrease in consolidated total assets, as compared with amounts
shown on the latest balance sheet included in the Prospectus; or

     (C) for the period from the closing date of the latest income statement
included in the Prospectus to the closing date of the latest available income
statement read by such accountants, or to a subsequent specified date not more
than three business days prior to the date of this Agreement, there were any
decreases, as compared with the corresponding period of the previous year, in
consolidated revenue or net operating income in the total or per share amounts
of consolidated net income;

     except in all cases set forth in clauses (B) and (C) above for changes,
increases or decreases which the Prospectus discloses have occurred or may occur
or which are described in such letter; and

     (iv) they have compared specified dollar amounts (or percentages derived
from such dollar amounts) and other financial information contained in the
Registration

15

--------------------------------------------------------------------------------

 

Statements (in each case to the extent that such dollar amounts, percentages and
other financial information are derived from the general accounting records of
the Company and its subsidiaries subject to the internal controls of the
Company’s accounting system or are derived directly from such records by
analysis or computation) with the results obtained from inquiries, a reading of
such general accounting records and other procedures specified in such letter
and have found such dollar amounts, percentages and other financial information
to be in agreement with such results, except as otherwise specified in such
letter.

For purposes of this subsection, (i) if the Effective Time of the Initial
Registration Statements is subsequent to the execution and delivery of this
Agreement, “Registration Statements” shall mean the initial registration
statement as proposed to be amended by the amendment or post-effective amendment
to be filed shortly prior to its Effective Time, (ii) if the Effective Time of
the Initial Registration Statements is prior to the execution and delivery of
this Agreement but the Effective Time of the Additional Registration Statement
is subsequent to such execution and delivery, “Registration Statements” shall
mean the Initial Registration Statement and the Additional Registration
Statement as proposed to be filed or as proposed to be amended by the
post-effective amendment to be filed shortly prior to its Effective Time, and
(iii) “Prospectus” shall mean the prospectus included in the Registration
Statements.

     (b) If the Effective Time of the Initial Registration Statement is not
prior to the execution and delivery of this Agreement, such Effective Time shall
have occurred not later than 10:00 P.M., New York time, on the date of this
Agreement or such later date as shall have been consented to by CSFB. If the
Effective Time of the Additional Registration Statement (if any) is not prior to
the execution and delivery of this Agreement, such Effective Time shall have
occurred not later than 10:00 P.M., New York time, on the date of this Agreement
or, if earlier, the time the Prospectus is printed and distributed to any
Underwriter, or shall have occurred at such later date as shall have been
consented to by CSFB. If the Effective Time of the Initial Registration
Statement is prior to the execution and delivery of this Agreement, the
Prospectus shall have been filed with the Commission in accordance with the
Rules and Regulations and Section 5(a) of this Agreement. Prior to such Closing
Date, no stop order suspending the effectiveness of a Registration Statement
shall have been issued and no proceedings for that purpose shall have been
instituted or, to the knowledge of any Selling Stockholder, the Company or the
Representative, shall be contemplated by the Commission.

     (c) Subsequent to the execution and delivery of this Agreement, there shall
not have occurred (i) any change, or any development or event involving a
prospective change, in the condition (financial or other), business, properties
or results of operations of the Company and its subsidiaries taken as one
enterprise which, in the judgment of a majority in interest of the Underwriters
including the Representative, is material and adverse and makes it impractical
or inadvisable to proceed with completion of the public offering or the sale of
and payment for the Offered Securities; (ii) any downgrading in the rating of
any debt securities of the Company by any “nationally recognized statistical
rating organization” (as defined for purposes of Rule 436(g) under the Act), or
any public announcement that any such organization has under surveillance or
review its rating of any debt securities of the Company (other than an
announcement with positive implications of a possible upgrading, and no
implication of a possible downgrading, of such rating); (iii) any change in U.S.
or international financial, political

16

--------------------------------------------------------------------------------

 

or economic conditions or currency exchange rates or exchange controls as would,
in the judgment of a majority in interest of the Underwriters including the
Representative, be likely to prejudice materially the success of the proposed
issue, sale or distribution of the Offered Securities, whether in the primary
market or in respect of dealings in the secondary market; (iv) any material
suspension or material limitation of trading in securities generally on the New
York Stock Exchange or any setting of minimum prices for trading on such
exchange; (v) any suspension of trading of any securities of the Company on any
exchange or in the over-the-counter market; (vi) any banking moratorium declared
by U.S. Federal or New York authorities; (vii) any major disruption of
settlements of securities or clearance services in the United States or
(viii) any attack on, outbreak or escalation of hostilities or act of terrorism
involving the United States, any declaration of war by Congress or any other
national or international calamity or emergency if, in the judgment of a
majority in interest of the Underwriters including the Representative, the
effect of any such attack, outbreak, escalation, act, declaration, calamity or
emergency makes it impractical or inadvisable to proceed with completion of the
public offering or the sale of and payment for the Offered Securities.

     (d) The Representative shall have received an opinion, dated such Closing
Date, of Kirkland & Ellis LLP, counsel for the Company, substantially in the
form of Exhibit A hereto.

     (e) If such Closing Date is the First Closing Date, the Representative
shall have received an opinion, dated such Closing Date, of Kirkland & Ellis
LLP, counsel for the Selling Stockholders listed on Schedule D-2, substantially
in the form of Exhibit B hereto.

     (f) If such Closing Date is the First Closing Date, the Representative
shall have received an opinion, dated such Closing Date, of Kaye Scholer LLP,
counsel for the Selling Stockholders listed on Schedule D-3, substantially in
the form of Exhibit C hereto.

     (g) If such Closing Date is the First Closing Date, the Representative
shall have received an opinion, dated such Closing Date, of Drinker Biddle &
Reath LLP, counsel for ASC Incorporated, substantially in the form of Exhibit D
hereto.

     (h) The Representative shall have received from Cravath, Swaine & Moore
LLP, counsel for the Underwriters, such opinion or opinions, dated such Closing
Date, with respect to the incorporation of the Company, the validity of the
Offered Securities delivered on such Closing Date, the Registration Statements,
the Prospectus and other related matters as the Representative may require, and
the Selling Stockholders and the Company shall have furnished to such counsel
such documents as they request for the purpose of enabling them to pass upon
such matters.

     (i) The Representative shall have received a certificate, dated such
Closing Date, of the President or any Vice President and a principal financial
or accounting officer of the Company in which such officers, to the best of
their knowledge after reasonable investigation, shall state that: the
representations and warranties of the Company in this Agreement are true and
correct; the Company has complied in all material respects with all agreements
and satisfied all conditions on its part to be performed or satisfied hereunder
at or prior to such Closing Date; no stop order suspending the effectiveness of
any Registration Statement has been issued and no proceedings for that purpose
have been instituted or are contemplated by the Commission; the Additional
Registration Statement (if any) satisfying the requirements of subparagraphs
(1) and (3) of Rule

17

--------------------------------------------------------------------------------

 

462(b) was filed pursuant to Rule 462(b), including payment of the applicable
filing fee in accordance with Rule 111(a) or (b) under the Act, prior to the
time the Prospectus was printed and distributed to any Underwriter; and,
subsequent to the date of the most recent financial statements in the
Prospectus, there has been no material adverse change, nor any development or
event involving a prospective material adverse change, in the condition
(financial or other), business, properties or results of operations of the
Company and its subsidiaries taken as a whole except as set forth in the
Prospectus or as described in such certificate.

     (j) The Representative shall have received a letter, dated such Closing
Date, of Deloitte & Touche LLP which meets the requirements of subsection (a) of
this Section, except that the specified date referred to in such subsection will
be a date not more than three days prior to such Closing Date for the purposes
of this subsection.

     (k) The Representative shall have received a certificate, dated such
Closing Date, from Chad M. Utrup, Chief Financial Officer of the Company,
substantially in the form of Exhibit E.

     (l) On or prior to the date of this Agreement, the Representative shall
have received lock-up letters from each of the executive officers and directors
of the Company and each existing stockholder of the Company substantially in the
form of Exhibit F.

     (m) The Custodian will deliver to CSFB a letter stating that they will
deliver to each Custodial Selling Stockholder a United States Treasury
Department Form 1099 (or other applicable form or statement specified by the
United States Treasury Department regulations in lieu thereof) on or before
January 31 of the year following the date of this Agreement.

The Selling Stockholders and the Company will furnish the Representative with
such conformed copies of such opinions, certificates, letters and documents as
the Representative reasonably requests. CSFB may in its sole discretion waive on
behalf of the Underwriters compliance with any conditions to the obligations of
the Underwriters hereunder, whether in respect of an Optional Closing Date or
otherwise.

     7. Indemnification and Contribution. (a) The Company will indemnify and
hold harmless each Underwriter, its partners, members, directors and officers
and each person, if any, who controls such Underwriter within the meaning of
Section 15 of the Act or Section 20 of the Exchange Act, against any losses,
claims, damages or liabilities, joint or several, to which such Underwriter may
become subject, under the Act or otherwise, insofar as such losses, claims,
damages or liabilities (or actions in respect thereof) arise out of or are based
upon any untrue statement or alleged untrue statement of any material fact
contained in any Registration Statement, the Prospectus, or any amendment or
supplement thereto, or any related preliminary prospectus, or arise out of or
are based upon the omission or alleged omission to state therein a material fact
required to be stated therein or necessary to make the statements therein not
misleading, and will reimburse each Underwriter for any legal or other expenses
reasonably incurred by such Underwriter in connection with investigating or
defending any such loss, claim, damage, liability or action as such expenses are
incurred; provided, however, that the Company will not be liable in any such
case to the extent that any such loss, claim, damage or liability arises out of
or is based upon an untrue statement or alleged untrue statement in or omission
or alleged omission from any of such documents in reliance upon and in
conformity with (a) written information furnished to the

18

--------------------------------------------------------------------------------

 

Company by any Underwriter through the Representative specifically for use
therein or (b) written information furnished to the Company by the Selling
Stockholders specifically for use therein, it being understood and agreed that
the only such information furnished by any Underwriter consists of the
information described as such in subsection (c) below.

     The Company agrees to indemnify and hold harmless the Designated
Underwriter and each person, if any, who controls the Designated Underwriter
within the meaning of either Section 15 of the Securities Act or Section 20 of
the Exchange Act (the “Designated Entities”), from and against any and all
losses, claims, damages and liabilities (including, without limitation, any
legal or other expenses reasonably incurred in connection with defending or
investigating any such action or claim) (i) caused by any untrue statement or
alleged untrue statement of a material fact contained in any material prepared
by or with the consent of the Company for distribution to Participants in
connection with the Directed Share Program or caused by any omission or alleged
omission to state therein a material fact required to be stated therein or
necessary to make the statements therein not misleading; (ii) caused by the
failure of any Participant to pay for and accept delivery of Directed Shares
that the Participant agreed to purchase; or (iii) related to, arising out of, or
in connection with the Directed Share Program, other than losses, claims,
damages or liabilities (or expenses relating thereto) that are finally
judicially determined to have resulted from the bad faith or gross negligence of
the Designated Entities.

     (b) Each Selling Stockholder, severally and not jointly will indemnify and
hold harmless each Underwriter, its partners, members, directors and officers
and each person who controls such Underwriter within the meaning of Section 15
of the Act or Section 20 of the Exchange Act, against any losses, claims,
damages or liabilities, joint or several, to which such Underwriter may become
subject, under the Act or otherwise, insofar as such losses, claims, damages or
liabilities (or actions in respect thereof) arise out of or are based upon any
untrue statement or alleged untrue statement of any material fact contained in
any Registration Statement, the Prospectus, or any amendment or supplement
thereto, or any related preliminary prospectus, or arise out of or are based
upon the omission or alleged omission to state therein a material fact required
to be stated therein or necessary to make the statements therein not misleading,
in each case to the extent, but only to the extent, that such untrue statement
or alleged untrue statement or omission or alleged omission was made in reliance
upon and in conformity with written information furnished to the Company by such
Selling Stockholder specifically for use therein, and will reimburse each
Underwriter for any legal or other expenses reasonably incurred by such
Underwriter in connection with investigating or defending any such loss, claim,
damage, liability or action as such expenses are incurred.

     (c) Each Underwriter will severally and not jointly indemnify and hold
harmless the Company, its directors and officers and each person, if any, who
controls the Company within the meaning of Section 15 of the Act or Section 20
of the Exchange Act, and each Selling Stockholder against any losses, claims,
damages or liabilities to which the Company or such Selling Stockholder may
become subject, under the Act or otherwise, insofar as such losses, claims,
damages or liabilities (or actions in respect thereof) arise out of or are based
upon any untrue statement or alleged untrue statement of any material fact
contained in any Registration Statement, the Prospectus, or any amendment or
supplement thereto, or any related preliminary prospectus, or arise out of or
are based upon the omission or the alleged omission to state therein a material
fact required to be stated therein or necessary to make the statements therein
not

19

--------------------------------------------------------------------------------

 

misleading, in each case to the extent, but only to the extent, that such untrue
statement or alleged untrue statement or omission or alleged omission was made
in reliance upon and in conformity with written information furnished to the
Company by such Underwriter through the Representative specifically for use
therein, and will reimburse any legal or other expenses reasonably incurred by
the Company and each Selling Stockholder in connection with investigating or
defending any such loss, claim, damage, liability or action as such expenses are
incurred, it being understood and agreed that the only such information
furnished by any Underwriter consists of the following information in the
Prospectus furnished on behalf of each Underwriter: the fourth, seventh,
fifteenth, sixteenth and seventeenth paragraphs, and the last two sentences in
the eighth paragraph under the caption “Underwriting”.

     (d) Promptly after receipt by an indemnified party under this Section or
Section 9 of notice of the commencement of any action, such indemnified party
will, if a claim in respect thereof is to be made against an indemnifying party
under subsection (a), (b) or (c) above or Section 9, notify the indemnifying
party of the commencement thereof in writing; but the failure to notify the
indemnifying party shall not relieve it from any liability that it may have
under subsection (a), (b) or (c) above or Section 9 except to the extent that it
has been materially prejudiced (through the forfeiture of substantive rights or
defenses) by such failure; and provided further that the failure to notify the
indemnifying party shall not relieve it from any liability that it may have to
an indemnified party otherwise than under subsection (a), (b) or (c) above or
Section 9. In case any such action is brought against any indemnified party and
it notifies an indemnifying party of the commencement thereof, the indemnifying
party will be entitled to participate therein and, to the extent that it may
wish, jointly with any other indemnifying party similarly notified, to assume
the defense thereof, with counsel reasonably satisfactory to such indemnified
party (who shall not, except with the consent of the indemnified party, be
counsel to the indemnifying party), and after notice from the indemnifying party
to such indemnified party of its election so to assume the defense thereof, the
indemnifying party will not be liable to such indemnified party under this
Section or Section 9, as the case may be, for any legal or other expenses
subsequently incurred by such indemnified party in connection with the defense
thereof other than reasonable costs of investigation. Notwithstanding anything
contained herein to the contrary, if indemnity may be sought pursuant to the
last paragraph in Section 7 (a) hereof in respect of such action or proceeding,
then in addition to such separate firm for the indemnified parties, the
indemnifying party shall be liable for the reasonable fees and expenses of not
more than one separate firm (in addition to any local counsel) for the
Designated Underwriter for the defense of any losses, claims, damages and
liabilities arising out of the Directed Share Program, and all persons, if any,
who control the Designated Underwriter within the meaning of either Section 15
of the Act of Section 20 of the Exchange Act. No indemnifying party shall,
without the prior written consent of the indemnified party, effect any
settlement of any pending or threatened action in respect of which any
indemnified party is or could have been a party and indemnity could have been
sought hereunder by such indemnified party unless such (i) settlement includes
an unconditional release of such indemnified party from all liability on any
claims that are the subject matter of such action and (ii) does not include a
statement as to, or an admission of, fault, culpability or a failure to act by
or on behalf of an indemnified party.

     (e) If the indemnification provided for in this Section is unavailable or
insufficient to hold harmless an indemnified party under subsection (a), (b) or
(c) above, then each indemnifying party shall contribute to the amount paid or
payable by such indemnified party as a

20

--------------------------------------------------------------------------------

 

result of the losses, claims, damages or liabilities referred to in subsection
(a), (b) or (c) above (i) in such proportion as is appropriate to reflect the
relative benefits received by the Company or such Selling Stockholder on the one
hand and the Underwriters on the other from the offering of the Securities or
(ii) if the allocation provided by clause (i) above is not permitted by
applicable law, in such proportion as is appropriate to reflect not only the
relative benefits referred to in clause (i) above but also the relative fault of
the Company or such Selling Stockholder on the one hand and the Underwriters on
the other in connection with the statements or omissions which resulted in such
losses, claims, damages or liabilities as well as any other relevant equitable
considerations. The relative benefits received by the Company or such Selling
Stockholder on the one hand and the Underwriters on the other shall be deemed to
be in the same proportion as the total net proceeds from the offering (before
deducting expenses) received by the Company or such Selling Stockholder bear to
the total underwriting discounts and commissions received by the Underwriters.
The relative fault shall be determined by reference to, among other things,
whether the untrue or alleged untrue statement of a material fact or the
omission or alleged omission to state a material fact relates to information
supplied by the Company, the Selling Stockholders or the Underwriters and the
parties’ relative intent, knowledge, access to information and opportunity to
correct or prevent such untrue statement or omission. The amount paid by an
indemnified party as a result of the losses, claims, damages or liabilities
referred to in the first sentence of this subsection (e) shall be deemed to
include any legal or other expenses reasonably incurred by such indemnified
party in connection with investigating or defending any action or claim which is
the subject of this subsection (e). Notwithstanding the provisions of this
subsection (e), no Underwriter shall be required to contribute any amount in
excess of the amount by which the total price at which the Securities
underwritten by it and distributed to the public were offered to the public
exceeds the amount of any damages which such Underwriter has otherwise been
required to pay by reason of such untrue or alleged untrue statement or omission
or alleged omission and no Selling Stockholder shall be required to contribute
an amount in excess of the net proceeds from the offering actually received by
such Selling Stockholder under this Agreement or to contribute any amount in
respect of losses, claims, damages or liabilities that it would not be obligated
to indemnify under Section 7(b). No person guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the Act) shall be
entitled to contribution from any person who was not guilty of such fraudulent
misrepresentation. The Underwriters’ obligations in this subsection (e) to
contribute are several in proportion to their respective underwriting
obligations and not joint.

     (f) The obligations of the Company and the Selling Stockholders under this
Section or Section 9 shall be in addition to any liability which the Company and
the Selling Stockholders may otherwise have and shall extend, upon the same
terms and conditions, to each person, if any, who controls any Underwriter or
the QIU (as hereinafter defined) within the meaning of the Act; and the
obligations of the Underwriters under this Section shall be in addition to any
liability which the respective Underwriters may otherwise have and shall extend,
upon the same terms and conditions, to each director of the Company, to each
officer of the Company who has signed a Registration Statement and to each
person, if any, who controls the Company within the meaning of the Act.

     (g) The aggregate liability of each Selling Stockholder under the indemnity
and contribution agreements contained in this Section 7 shall be limited to an
amount equal to the net

21

--------------------------------------------------------------------------------

 

proceeds from the offering of the Securities provided hereunder actually
received by such Selling Stockholder hereunder.

     8. Default of Underwriters. If any Underwriter or Underwriters default in
their obligations to purchase Offered Securities hereunder on either the First
or any Optional Closing Date and the aggregate number of shares of Offered
Securities that such defaulting Underwriter or Underwriters agreed but failed to
purchase does not exceed 10% of the total number of shares of Offered Securities
that the Underwriters are obligated to purchase on such Closing Date, CSFB may
make arrangements satisfactory to the Company and the Selling Stockholders for
the purchase of such Offered Securities by other persons, including any of the
Underwriters, but if no such arrangements are made by such Closing Date, the
non-defaulting Underwriters shall be obligated severally, in proportion to their
respective commitments hereunder, to purchase the Offered Securities that such
defaulting Underwriters agreed but failed to purchase on such Closing Date. If
any Underwriter or Underwriters so default and the aggregate number of shares of
Offered Securities with respect to which such default or defaults occur exceeds
10% of the total number of shares of Offered Securities that the Underwriters
are obligated to purchase on such Closing Date and arrangements satisfactory to
CSFB, the Company and the Selling Stockholders for the purchase of such Offered
Securities by other persons are not made within 36 hours after such default,
this Agreement will terminate without liability on the part of any
non-defaulting Underwriter, the Company or the Selling Stockholders, except as
provided in Section 10 (provided that if such default occurs with respect to
Optional Securities after the First Closing Date, this Agreement will not
terminate as to the Firm Securities or any Optional Securities purchased prior
to such termination). As used in this Agreement, the term “Underwriter” includes
any person substituted for an Underwriter under this Section. Nothing herein
will relieve a defaulting Underwriter from liability for its default.

     9. Qualified Independent Underwriter. The Company hereby confirms that at
its request CSFB has without compensation acted as “qualified independent
underwriter” (in such capacity, the “QIU”) within the meaning of Rule 2710 of
the Conduct Rules of the National Association of Securities Dealers, Inc. in
connection with the offering of the Offered Securities. The Company and the
Selling Stockholders will severally and not jointly indemnify and hold harmless
the QIU against any losses, claims, damages or liabilities, joint or several, to
which the QIU may become subject, under the Act or otherwise, insofar as such
losses, claims, damages or liabilities (or actions in respect thereof) arise out
of or are based upon the QIU’s acting (or alleged failing to act) as such
“qualified independent underwriter” and will reimburse the QIU for any legal or
other expenses reasonably incurred by the QIU in connection with investigating
or defending any such loss, claim, damage, liability or action as such expenses
are incurred.

     10. Survival of Certain Representations and Obligations. The respective
indemnities, agreements, representations, warranties and other statements of the
several Selling Stockholders, of the Company or its officers and of the several
Underwriters set forth in or made pursuant to this Agreement will remain in full
force and effect, regardless of any investigation, or statement as to the
results thereof, made by or on behalf of any Underwriter, any Selling
Stockholder, the Company or any of their respective representatives, officers or
directors or any controlling person, and will survive delivery of and payment
for the Offered Securities. If this Agreement is terminated pursuant to
Section 8 or if for any reason the purchase of the Offered Securities by the
Underwriters is not consummated, the Company and the Selling Stockholders shall
remain responsible for the expenses to be paid or reimbursed by them pursuant to
Section 5 and the respective obligations of

22

--------------------------------------------------------------------------------

 

the Company, the Selling Stockholders, and the Underwriters pursuant to
Section 7 shall remain in effect, and if any Offered Securities have been
purchased hereunder the representations and warranties in Section 2 and all
obligations under Section 5 shall also remain in effect. If the purchase of the
Offered Securities by the Underwriters is not consummated for any reason other
than solely because of the termination of this Agreement pursuant to Section 8
or the occurrence of any event specified in clause (iii), (iv), (vi), (vii) or
(viii) of Section 6(c), the Company will reimburse the Underwriters for all
out-of-pocket expenses (including fees and disbursements of counsel) reasonably
incurred by them in connection with the offering of the Offered Securities.

     11. Notices. All communications hereunder will be in writing and, if sent
to the Underwriters, will be mailed, delivered or faxed and confirmed to the
Representative at Eleven Madison Avenue, New York, NY 10010-3629, Attention:
Transactions Advisory Group, or, if sent to the Company, will be mailed,
delivered or faxed and confirmed to it at Commercial Vehicle Group, Inc., 6530
West Campus Way, New Albany, Ohio 43054, Attention: Mervin Dunn, President and
Chief Executive Officer, or, if sent to the Selling Stockholders or any of them,
will be mailed, delivered or faxed and confirmed to each of them at its
respective address set forth on Schedule A hereto; provided, however, that any
notice to an Underwriter pursuant to Section 7 will be mailed, delivered or
telegraphed and confirmed to such Underwriter.

     12. Successors. This Agreement will inure to the benefit of and be binding
upon the parties hereto and their respective personal representatives and
successors and the officers and directors and controlling persons referred to in
Section 7, and no other person will have any right or obligation hereunder.

     13. Representation. The Representative will act for the several
Underwriters in connection with the transactions contemplated by this Agreement,
and any action under this Agreement taken by the Representative will be binding
upon all the Underwriters. Hidden Creek Industries will act for the Custodial
Selling Stockholders in connection with such transactions, and any action under
or in respect of this Agreement taken by Hidden Creek Industries will be binding
upon all the Custodial Selling Stockholders. Onex American Holdings II LLC will
act for the Onex Selling Stockholders in connection with such transactions, and
any action under or in respect of this Agreement taken by Onex American Holdings
II LLC will be binding upon all the Onex Selling Stockholders.

     14. Counterparts. This Agreement may be executed in any number of
counterparts, each of which shall be deemed to be an original, but all such
counterparts shall together constitute one and the same Agreement.

     15. Applicable Law. This Agreement shall be governed by, and construed in
accordance with, the laws of the State of New York.

     The Company hereby submits to the non-exclusive jurisdiction of the Federal
and state courts in the Borough of Manhattan in The City of New York in any suit
or proceeding arising out of or relating to this Agreement or the transactions
contemplated hereby.

23

--------------------------------------------------------------------------------

 

     If the foregoing is in accordance with the Representative’s understanding
of our agreement, kindly sign and return to the Company one of the counterparts
hereof, whereupon it will become a binding agreement among the Selling
Stockholders, the Company and the several Underwriters in accordance with its
terms.

                      Very truly yours,
 
                        COMMERCIAL VEHICLE GROUP, INC.,
 
               

          By     /s/ Chad M. Utrup

             

--------------------------------------------------------------------------------

 

              Name: Chad M. Utrup

              Title: Vice President & CFO
 
                        ONEX AMERICAN HOLDINGS II LLC,
 
               

          By     /s/ Eric J. Rosen

             

--------------------------------------------------------------------------------

 

              Name:

              Title:
 
                        BOSTROM EXECUTIVE INVESTCO LLC,
 
               

          By     /s/ Eric J. Rosen

             

--------------------------------------------------------------------------------

 

              Name:

              Title:
 
                        CVS EXECUTIVE INVESTCO LLC,
 
               

          By     /s/ Eric J. Rosen

             

--------------------------------------------------------------------------------

 

              Name:

              Title:
 
                        ONEX DHC LLC,
 
               

          By     /s/ Eric J. Rosen

             

--------------------------------------------------------------------------------

 

              Name:

              Title:

24

--------------------------------------------------------------------------------

 

                 
 
                        TRIM SYSTEMS EXECUTIVE INVESTCO LLC,
 
               

          By     /s/ Eric J. Rosen

             

--------------------------------------------------------------------------------

 

              Name:

              Title:
 
                        TRIM SYSTEMS EXECUTIVE INVESTCO II LLC,
 
               

          By     /s/ Eric J. Rosen

             

--------------------------------------------------------------------------------

 

              Name:

              Title:
 
                        BOSTROM PARTNERS LP,
 
               

          By     /s/ Eric J. Rosen

             

--------------------------------------------------------------------------------

 

              Name:

              Title:
 
                        1170821 ONTARIO INC.,
 
               

          By     /s/ Eric J. Rosen

             

--------------------------------------------------------------------------------

 

              Name:

              Title:
 
                        1170809 ONTARIO INC.,
 
               

          By     /s/ Eric J. Rosen

             

--------------------------------------------------------------------------------

 

              Name:

              Title:
 
                        1170812 ONTARIO INC.,
 
               

          By     /s/ Eric J. Rosen

             

--------------------------------------------------------------------------------

 

              Name:

              Title:

25

--------------------------------------------------------------------------------

 

                 
 
                        KYZALEA COMPANY,
 
               

          By     /s/ Eric J. Rosen

             

--------------------------------------------------------------------------------

 

              Name:

              Title:
 
                        1170819 ONTARIO INC.,
 
               

          By     /s/ Eric J. Rosen

             

--------------------------------------------------------------------------------

 

              Name:

              Title:
 
                        1170698 ONTARIO INC.,
 
               

          By     /s/ Eric J. Rosen

             

--------------------------------------------------------------------------------

 

              Name:

              Title:
 
                        1301449 ONTARIO INC.,
 
               

          By     /s/ Eric J. Rosen

             

--------------------------------------------------------------------------------

 

              Name:

              Title:
 
                        1352536 ONTARIO INC.
 
               

          By     /s/ Eric J. Rosen

             

--------------------------------------------------------------------------------

 

              Name:

              Title:
 
                        1376653 ONTARIO INC.,
 
               

          By     /s/ Eric J. Rosen

             

--------------------------------------------------------------------------------

 

              Name:

              Title:

26

--------------------------------------------------------------------------------

 

                          1352537 ONTARIO INC.,
 
               

          By     /s/ Eric J. Rosen

             

--------------------------------------------------------------------------------

 

              Name:

              Title:
 
                        TIM DUNCANSON,
 
               

          By     /s/ Eric J. Rosen

             

--------------------------------------------------------------------------------

 

              Name:

              Title:
 
                        3-G INVESTMENTS LIMITED,
 
               

          By     /s/ Eric J. Rosen

             

--------------------------------------------------------------------------------

 

              Name:

              Title:
 
                        SERGE GOUIN,
 
               

          By     /s/ Eric J. Rosen

             

--------------------------------------------------------------------------------

 

              Name:

              Title:
 
                        BRIAN KING,
 
               

          By     /s/ Eric J. Rosen

             

--------------------------------------------------------------------------------

 

              Name:

              Title:
 
                        J.W.E. MINGO,
 
               

          By     /s/ Eric J. Rosen

             

--------------------------------------------------------------------------------

 

              Name:

              Title:

27

--------------------------------------------------------------------------------

 

                          ROBERT PRICHARD,
 
               

          By     /s/ Eric J. Rosen

             

--------------------------------------------------------------------------------

 

              Name:

              Title:
 
                        1299039 ONTARIO INC.,
 
               

          By     /s/ Eric J. Rosen

             

--------------------------------------------------------------------------------

 

              Name:

              Title:
 
                        2668921 MANITOBA LTD.,
 
               

          By     /s/ Eric J. Rosen

             

--------------------------------------------------------------------------------

 

              Name:

              Title:
 
                        ONEX ADVISOR III LLC,
 
               

          By     /s/ Eric J. Rosen

             

--------------------------------------------------------------------------------

 

              Name:

              Title:
 
                        CVS PARTNERS, LP,
 
               

          By     /s/ Eric J. Rosen

             

--------------------------------------------------------------------------------

 

              Name:

              Title:
 
                        3062601 NOVA SCOTIA COMPANY,
 
               

          By     /s/ Eric J. Rosen

             

--------------------------------------------------------------------------------

 

              Name:

              Title:

28

--------------------------------------------------------------------------------

 

                          HIDDEN CREEK INDUSTRIES,
 
               

          By     /s/ Daniel F. Moorse

             

--------------------------------------------------------------------------------

 

              Name:

              Title:
 
                        AMON CANADIAN INVESTMENTS LTD.,
 
               

          By     /s/ Eric J. Rosen

             

--------------------------------------------------------------------------------

 

              Name:

              Title:
 
                        MHON CANADIAN INVESTMENTS LTD.,
 
               

          By     /s/ Eric J. Rosen

             

--------------------------------------------------------------------------------

 

              Name:

              Title:
 
                        BAIRD CAPITAL PARTNERS III L.P.,
 
               

          By     /s/ Daniel F. Moorse

             

--------------------------------------------------------------------------------

 

              Name:

              Title:
 
                        BAIRD CAPITAL PARTNERS II L.P.,
 
               

          By     /s/ Daniel F. Moorse

             

--------------------------------------------------------------------------------

 

              Name:

              Title:
 
                        BCP III AFFILIATES FUND L.P.,
 
               

          By     /s/ Daniel F. Moorse

             

--------------------------------------------------------------------------------

 

              Name:

              Title:

29

--------------------------------------------------------------------------------

 

                          BCP III SPECIAL AFFILIATES L.P.,
 
               

          By     /s/ Daniel F. Moorse

             

--------------------------------------------------------------------------------

 

              Name:

              Title:
 
                        BCP II AFFILIATES FUND L.P.,
 
               

          By     /s/ Daniel F. Moorse

             

--------------------------------------------------------------------------------

 

              Name:

              Title:
 
                        NORWEST EQUITY PARTNERS VII L.P.,
 
               

          By     /s/ Daniel F. Moorse

             

--------------------------------------------------------------------------------

 

              Name:

              Title:
 
                        KENNETH W. HAGER,
 
               

          By     /s/ Daniel F. Moorse

             

--------------------------------------------------------------------------------

 

              Name:

              Title:
 
                        DAVID J. HULS,
 
               

          By     /s/ Daniel F. Moorse

             

--------------------------------------------------------------------------------

 

              Name:

              Title:
 
                        S.A. JOHNSON,
 
               

          By     /s/ Daniel F. Moorse

             

--------------------------------------------------------------------------------

 

              Name:

              Title:

30

--------------------------------------------------------------------------------

 

                          DANIEL F. MOORSE,
 
               

          By     /s/ Daniel F. Moorse

             

--------------------------------------------------------------------------------

 

              Name:

              Title:
 
                        CARL E. NELSON,
 
               

          By     /s/ Daniel F. Moorse

             

--------------------------------------------------------------------------------

 

              Name:

              Title:
 
                        JUDITH A. VIJUMS,
 
               

          By     /s/ Daniel F. Moorse

             

--------------------------------------------------------------------------------

 

              Name:

              Title:
 
                        MARNI L. NAGY,
 
               

          By     /s/ Daniel F. Moorse

             

--------------------------------------------------------------------------------

 

              Name:

              Title:
 
                        RONALD A. JOHNSON,
 
               

          By     /s/ Daniel F. Moorse

             

--------------------------------------------------------------------------------

 

              Name:

              Title:
 
                        RANDOLPH STREET PARTNERS II,
 
               

          By     /s/ Daniel F. Moorse

             

--------------------------------------------------------------------------------

 

              Name:

              Title:

31

--------------------------------------------------------------------------------

 

                          ROBERT R. HIBBS,
 
               

          By     /s/ Daniel F. Moorse

             

--------------------------------------------------------------------------------

 

              Name:

              Title:
 
                        MARY-LOUISE R. JOHNSON TRUST,
 
               

          By     /s/ Daniel F. Moorse

             

--------------------------------------------------------------------------------

 

              Name:

              Title:
 
                        MICHAEL SZCZEPANSKI,
 
               

          By     /s/ Daniel F. Moorse

             

--------------------------------------------------------------------------------

 

              Name:

              Title:
 
                        ASC INCORPORATED,
 
               

          By     /s/ Daniel F. Moorse

             

--------------------------------------------------------------------------------

 

              Name:

              Title:

32

--------------------------------------------------------------------------------

 

The foregoing Underwriting Agreement is hereby confirmed and accepted as of the
date first above written.

                  CREDIT SUISSE FIRST BOSTON LLC    
 
           

  By   /s/ Edward P. Witz

--------------------------------------------------------------------------------

   

      Name: Edward P. Witz    

      Title: Managing Director    

Acting on behalf of itself and as the Representative of the several
Underwriters.

33

--------------------------------------------------------------------------------

 

SCHEDULE A

                      Number of Firm         Securities Selling Stockholder

--------------------------------------------------------------------------------

  Address

--------------------------------------------------------------------------------

  to be Sold

--------------------------------------------------------------------------------

Onex American Holdings II LLC
  c/o Onex Investment Corp.     2,159,033  

  712 Fifth Avenue        

  New York, NY 10019        
 
           
Bostrom Executive Investco LLC
  c/o Onex Investment Corp.     94,389  

  712 Fifth Avenue        

  New York, NY 10019        
 
           
CVS Executive Investco LLC
  c/o Onex Investment Corp.     66,197  

  712 Fifth Avenue        

  New York, NY 10019        
 
           
Onex DHC LLC
  c/o Onex Investment Corp.     1,008,939  

  712 Fifth Avenue        

  New York, NY 10019        
 
           
Trim Systems Executive Investco LLC
  c/o Onex Investment Corp.     39,194  

  712 Fifth Avenue        

  New York, NY 10019        
 
           
Trim Systems Executive Investco II LLC
  c/o Onex Investment Corp.     33,422  

  712 Fifth Avenue        

  New York, NY 10019        
 
           
Bostrom Partners LP
  c/o Onex Investment Corp.     21,983  

  712 Fifth Avenue        

  New York, NY 10019        
 
           
1170821 Ontario Inc.
  c/o Onex Investment Corp.     15,675  

  712 Fifth Avenue        

  New York, NY 10019        
 
           
1170809 Ontario Inc.
  c/o Onex Investment Corp.     13,166  

  712 Fifth Avenue        

  New York, NY 10019        
 
           
1170812 Ontario Inc.
  c/o Onex Investment Corp.     22,495  

  712 Fifth Avenue        

  New York, NY 10019        
 
           
Kyzalea Company
  c/o Onex Investment Corp.     7,202  

  712 Fifth Avenue        

  New York, NY 10019        

34

--------------------------------------------------------------------------------

 

                      Number of Firm         Securities Selling Stockholder

--------------------------------------------------------------------------------

  Address

--------------------------------------------------------------------------------

  to be Sold

--------------------------------------------------------------------------------

1170819 Ontario Inc.
  c/o Onex Investment Corp.     5,227  

  712 Fifth Avenue        

  New York, NY 10019        
 
           
1170698 Ontario Inc.
  c/o Onex Investment Corp.     4,518  

  712 Fifth Avenue        

  New York, NY 10019        
 
           
1301449 Ontario Inc.
  c/o Onex Investment Corp.     2,063  

  712 Fifth Avenue        

  New York, NY 10019        
 
           
1352536 Ontario Inc.
  c/o Onex Investment Corp.     1,158  

  712 Fifth Avenue        

  New York, NY 10019        
 
           
1376653 Ontario Inc.
  c/o Onex Investment Corp.     493  

  712 Fifth Avenue        

  New York, NY 10019        
 
           
1352537 Ontario Inc.
  c/o Onex Investment Corp.     147  

  712 Fifth Avenue        

  New York, NY 10019        
 
           
Tim Duncanson
  c/o Onex Investment Corp.     439  

  712 Fifth Avenue        

  New York, NY 10019        
 
           
3-G Investments Limited
  c/o Onex Investment Corp.     13,180  

  712 Fifth Avenue        

  New York, NY 10019        
 
           
Serge Gouin
  c/o Onex Investment Corp.     8,787  

  712 Fifth Avenue        

  New York, NY 10019        
 
           
Brian King
  c/o Onex Investment Corp.     1,318  

  712 Fifth Avenue        

  New York, NY 10019        
 
           
J.W.E. Mingo
  c/o Onex Investment Corp.     879  

  712 Fifth Avenue        

  New York, NY 10019        
 
           
Robert Prichard
  c/o Onex Investment Corp.     4,393  

  712 Fifth Avenue        

  New York, NY 10019        

35

--------------------------------------------------------------------------------

 

                      Number of Firm         Securities Selling Stockholder

--------------------------------------------------------------------------------

  Address

--------------------------------------------------------------------------------

  to be Sold

--------------------------------------------------------------------------------

1299039 Ontario Inc.
  c/o Onex Investment Corp.     879  

  712 Fifth Avenue        

  New York, NY 10019        
 
           
2668921 Manitoba Ltd.
  c/o Onex Investment Corp.     2636  

  712 Fifth Avenue        

  New York, NY 10019        
 
           
Onex Advisor III LLC
  c/o Onex Investment Corp.     257,546  

  712 Fifth Avenue        

  New York, NY 10019        
 
           
CVS Partners, LP
  c/o Onex Investment Corp.     15,417  

  712 Fifth Avenue        

  New York, NY 10019        
 
           
3062601 Nova Scotia Company
  c/o Onex Investment Corp.     20,035  

  712 Fifth Avenue        

  New York, NY 10019        
 
           
Hidden Creek Industries
  4508 IDS Center     44,195  

  Minneapolis, MN 55402        
 
           
AMON Canadian Investments Ltd.
  c/o Onex Investment Corp.     2,002  

  712 Fifth Avenue        

  New York, NY 10019        
 
           
MHON Canadian Investments Ltd.
  c/o Onex Investment Corp.     1,891  

  712 Fifth Avenue        

  New York, NY 10019        
 
           
Baird Capital Partners III L.P.
  c/o Baird Capital Partners     564,958  

  227 West Monroe Street        

  Suite 2200        

  Chicago, IL 60606        

  Attn: C. Andrew Brickman        
 
           
Baird Capital Partners II L.P.
  c/o Baird Capital Partners     117,840  

  227 West Monroe Street        

  Suite 2200        

  Chicago, IL 60606        

  Attn: C. Andrew Brickman        

36

--------------------------------------------------------------------------------

 

                      Number of Firm         Securities Selling Stockholder

--------------------------------------------------------------------------------

  Address

--------------------------------------------------------------------------------

  to be Sold

--------------------------------------------------------------------------------

BCP III Affiliates Fund L.P.
  c/o Baird Capital Partners     112,999  

  227 West Monroe Street        

  Suite 2200        

  Chicago, IL 60606        

  Attn: C. Andrew Brickman        
 
           
BCP III Special Affiliates L.P.
  c/o Baird Capital Partners     80,611  

  227 West Monroe Street        

  Suite 2200        

  Chicago, IL 60606        

  Attn: C. Andrew Brickman        
 
           
BCP II Affiliates Fund L.P.
  c/o Baird Capital Partners     69,924  

  227 West Monroe Street        

  Suite 2200        

  Chicago, IL 60606        

  Attn: C. Andrew Brickman        
 
           
Norwest Equity Partners VII L.P.
  3600 IDS Center     1,006,416  

  80 South 8th Street        

  Minneapolis, MN 55402        
 
           
Kenneth W. Hager
  c/o Hidden Creek     10,820  

  4508 IDS Center        

  Minneapolis, MN 55402        
 
           
David J. Huls
  c/o Hidden Creek     20,744  

  4508 IDS Center        

  Minneapolis, MN 55402        
 
           
S.A. Johnson
  c/o OG Partners     103,452  

  294 Grove Lane East        

  Ste. 260        

  Wayzata, MN 55391        
 
           
Daniel F. Moorse
  c/o Hidden Creek     18,618  

  4508 IDS Center        

  Minneapolis, MN 55402        
 
           
Carl E. Nelson
  c/o Hidden Creek     22,005  

  4508 IDS Center        

  Minneapolis, MN 55402        
 
           
Judith A. Vijums
  c/o Hidden Creek     18,933  

  4508 IDS Center        

  Minneapolis, MN 55402        

37

--------------------------------------------------------------------------------

 

                      Number of Firm         Securities Selling Stockholder

--------------------------------------------------------------------------------

  Address

--------------------------------------------------------------------------------

  to be Sold

--------------------------------------------------------------------------------

Marni L. Nagy
  20072 Trabuco Oaks Drive     4,819  

  PO Box 987        

  Trabuco Canyon, CA 92678        
 
           
Ronald A. Johnson
  3702 Moorpark Avenue     4,819  

  San Jose, CA 95117        
 
           
Randolph Street Partners II
  c/o Kirkland & Ellis LLP     33,804  

  200 E. Randolph Drive        

  Chicago, IL 60601        
 
           
Robert R. Hibbs
  3415 NE 2nd Avenue     2,522  

  Suite 203        

  Miami, FL 33137        
 
           
Mary-Louise R. Johnson Trust
  c/o Hidden Creek     1,261  

  4508 IDS Center        

  Minneapolis, MN 55402        
 
           
Michael Szczepanski
  5104 N. Graham     861  

  Charlotte, NC 28269        
 
           
ASC Incorporated
  One ASC Center     60,696  
 
  Southgate, MI 48195        

       

--------------------------------------------------------------------------------

   
Total
        6,125,000  

       

--------------------------------------------------------------------------------

   

38

--------------------------------------------------------------------------------

 

SCHEDULE B

              Number of     Firm Securities Underwriter

--------------------------------------------------------------------------------

  to be Purchased

--------------------------------------------------------------------------------

Credit Suisse First Boston LLC
    4,301,250  
Lehman Brothers Inc.
    2,127,500  
Robert W. Baird & Co. Incorporated
    2,127,500  
RBC Capital Markets Corporation
    693,750  
 
   

--------------------------------------------------------------------------------

   
Total
    9,250,000  
 
   

--------------------------------------------------------------------------------

   

39

--------------------------------------------------------------------------------

 

SCHEDULE C

SUBSIDIARIES OF COMMERCIAL VEHICLE GROUP, INC.

                          Significant     Entity

--------------------------------------------------------------------------------

  Jurisdiction

--------------------------------------------------------------------------------

  Subsidiary

--------------------------------------------------------------------------------

1.
  Trim Systems, Inc.   Delaware   Yes
2.
  Trim Systems Operating Corp.   Delaware    
3.
  Trim Systems LLC   Delaware   Yes
4.
  Tempress, Inc.   Washington   Yes
5.
  CVG International Holdings Limited   Barbados    
6.
  CVG (Shanghai), Co. LTD.   China    
7.
  CVS Holdings Limited   United Kingdom   Yes
8.
  Commercial Vehicle Systems Limited   United Kingdom   Yes
9.
  Bostrom Limited   United Kingdom   Yes
10.
  Bostrom Investments Limited   United Kingdom    
11.
  KAB Seating LLC   United Kingdom    
12.
  Bostrom International Limited   United Kingdom   Yes
13.
  KAB Seating, AB   Sweden    
14.
  KAB Seating, Pty   Australia    
15.
  KAB Seating, S.A.   Belgium    
16.
  National Seating Company   Delaware   Yes
17.
  KAB Seating Limited   United Kingdom   Yes
18.
  A. Stokes Pressings Limited   United Kingdom    
19.
  Wilton & Co. Pressings Limited   United Kingdom    
20.
  Bostrom Specialist Engineering Limited   United Kingdom    
21.
  Winston Cable Limited   United Kingdom    
22.
  JMH Limited   United Kingdom    
23.
  KAB Tooling Limited   United Kingdom    
24.
  Bostrom Europe   United Kingdom    
25.
  The C&P Jig & Tool Limited   United Kingdom    
26.
  BB Seating Limited   United Kingdom    
27.
  Palmer & Shelley Limited   United Kingdom    
28.
  AJW Holdings Limited   United Kingdom    
29.
  KAB Industries Limited   United Kingdom    
30.
  Corvus Suspension Products Limited   United Kingdom    
31.
  KAB Pressings Limited   United Kingdom    
32
  KAB Components Limited   United Kingdom    
33.
  AJ Williams Small Pressings Limited   United Kingdom    
34.
  Bostrom Vehicle Components Limited   United Kingdom    
35.
  Inbark Limited   United Kingdom    
36.
  KAB Engineering Limited   United Kingdom    
37.
  CVS Holdings, Inc.   Delaware   Yes
38.
  Commercial Vehicle Systems, Inc.   Delaware   Yes

 

--------------------------------------------------------------------------------

 

SCHEDULE D-1

Baird Capital Partners III L.P.
Baird Capital Partners II L.P.
BCP III Affiliates Fund L.P.
BCP III Special Affiliates L.P.
BCP II Affiliates Fund L.P.
Norwest Equity Partners VII L.P.
Kenneth W. Hager
David J. Huls
S.A. Johnson
Daniel F. Moorse
Carl E. Nelson
Judith A. Vijums
Marni L. Nagy
Ronald A. Johnson
Randolph Street Partners II
Robert R. Hibbs
Mary-Louise R. Johnson Trust
Michael Szczepanski
Hidden Creek Industries

 

--------------------------------------------------------------------------------

 

SCHEDULE D-2

Kenneth W. Hager
David J. Huls
S.A. Johnson
Daniel F. Moorse
Carl E. Nelson
Judith A. Vijums
Marni L. Nagy
Ronald A. Johnson
Randolph Street Partners II
Robert R. Hibbs
Mary-Louise R. Johnson Trust
Michael Szczepanski
Hidden Creek Industries

 

--------------------------------------------------------------------------------

 

SCHEDULE D-3

Onex American Holdings II LLC
Bostrom Executive Investco LLC
CVS Executive Investco LLC
Onex DHC LLC
Trim Systems Executive Investco LLC
Trim Systems Executive Investco II LLC
Bostrom Partners LP
1170821 Ontario Inc.
1170809 Ontario Inc.
1170812 Ontario Inc.
Kyzalea Company
1170819 Ontario Inc.
1170698 Ontario Inc.
1301449 Ontario Inc.
1352536 Ontario Inc.
1376653 Ontario Inc.
1352537 Ontario Inc.
Tim Duncanson
3-G Investments Limited
Serge Gouin
Brian King
J.W.E. Mingo
Robert Prichard
1299039 Ontario Inc.
2668921 Manitoba Ltd
Onex Advisor III LLC
CVS Partners, LP
3062601 Nova Scotia Company
AMON Canadian Investments Ltd.
MHON Canadian Investments Ltd.
Baird Capital Partners III L.P.
Baird Capital Partners II L.P.
BCP III Affiliates Fund L.P.
BCP III Special Affiliates L.P.
BCP II Affiliates Fund L.P.
Norwest Equity Partners VII L.P.

 

--------------------------------------------------------------------------------

 

EXHIBIT A

OPINION OF KIRKLAND & ELLIS LLP

 

--------------------------------------------------------------------------------

 

EXHIBIT B

OPINION OF KIRKLAND & ELLIS LLP

 

--------------------------------------------------------------------------------

 

EXHIBIT C

OPINION OF KAYE SCHOLER LLP

 

--------------------------------------------------------------------------------

 

EXHIBIT D

OPINION OF DRINKER BIDDLE & REATH LLP

 

--------------------------------------------------------------------------------

 

EXHIBIT E

CERTIFICATE OF CHIEF FINANCIAL OFFICER

[     ], 2004

Credit Suisse First Boston LLC
Eleven Madison Avenue
New York, NY 10010

Dear Sirs:

     In 2002, Trim Systems Operating Corp., Commercial Vehicle Systems Holdings,
Inc. and CVS Holdings Ltd. (the “Constituent Entities”) dismissed their
independent auditors, Arthur Andersen LLP (“Andersen”) and engaged the services
of Deloitte & Touche LLP (“Deloitte”) as their new independent auditors for the
fiscal year ending December 31, 2002. The boards of directors and audit
committees of each of the Constituent Entities authorized the dismissal of
Andersen and the engagement of Deloitte. Given this change in independent public
accountants, you have asked me to provide you with certain information as of the
date hereof in connection with the offering (the “Offering”) of Common Stock,
par value $0.01 per share (the “Securities”) of the Company. To that end, in my
capacity as Chief Financial Officer of the Company, I do hereby certify to the
best of my knowledge based upon a review of the financial records and schedules
of the Company made by me or members of my staff that:

     Nothing has come to my attention that would cause me to believe that the
consolidated balance sheets of the Company as of December 31, 1999 and 2000 and
the related financial data included in the registration statement (No.
333-115708) on Form S-1 filed by the Company under the Securities Act of 1933
(the “Registration Statement”) do not fairly represent the financial position of
the Company and its subsidiaries in all material respects in conformity with
accounting principles generally accepted in the United States.

     I, or members of my staff, have read the items marked on the attached
copies of selected pages of the Registration Statement and have performed the
following procedures, which were applied as indicated by the letters set forth
below:

          A. Agreed to or derived from the Constituent Entities’ separate
financial statements (which were individually audited by Andersen) which have
been combined as a result of their merger, after giving effect to the required
generally accepted accounting principles adjustments as a result of the merger
of the Constituent Entities.

          B. Proved the arithmetic accuracy based on amounts in or derived from
the Constituent Entities’ separate financial statements (which were individually
audited by Andersen) which have been combined as a result of their merger, after
giving effect to the required generally accepted accounting principles
adjustments as a result of the merger of the Constituent Entities.

     This letter is being provided solely for the information of Credit Suisse
First Boston LLC, as representative of the underwriters, to assist the
underwriters in conducting and documenting their investigation of the affairs of
the Company in connection with the Offering, and this letter is not to be used,
circulated, quoted or otherwise referred to for any purpose.

 

--------------------------------------------------------------------------------

 

     To evidence my certification as an officer of the Company of the foregoing
information, I have set my hand to this letter on the date first written above.

            Very truly yours,

COMMERCIAL VEHICLE GROUP, INC.,
          by

        Name:   Chad M. Utrup        Title:   Chief Financial Officer   

 

--------------------------------------------------------------------------------

 

         

EXHIBIT F

FORM OF LOCK-UP AGREEMENT

Commercial Vehicle Group, Inc.
6530 West Campus Way
New Albany, Ohio 43054

Credit Suisse First Boston LLC
Lehman Brothers Inc.
Robert W. Baird & Co. Incorporated
(collectively, the “Underwriters”)

c/o   Credit Suisse First Boston LLC
Eleven Madison Avenue
New York, NY 10010-3629

     Dear Sirs:

     As an inducement to the Underwriters to execute the Underwriting Agreement
(the “Underwriting Agreement”), pursuant to which an offering (the “Offering”)
will be made that is intended to result in the establishment of a public market
for the common stock, par value $0.01 per share (the “Securities”) of Commercial
Vehicle Group, Inc., and any successor (by merger or otherwise) thereto (the
“Company”), the undersigned hereby agrees that during the period specified in
the following paragraph (the “Lock-Up Period”), the undersigned will not offer,
sell, contract to sell, pledge or otherwise dispose of, directly or indirectly,
any shares of Securities or securities convertible into or exchangeable or
exercisable for any shares of Securities, enter into a transaction which would
have the same effect, or enter into any swap, hedge or other arrangement that
transfers, in whole or in part, any of the economic consequences of ownership of
the Securities, whether any such aforementioned transaction is to be settled by
delivery of the Securities or such other securities, in cash or otherwise, or
publicly disclose the intention to make any such offer, sale, pledge or
disposition, or to enter into any such transaction, swap, hedge or other
arrangement, without, in each case, the prior written consent of Credit Suisse
First Boston LLC (“CSFB”). In addition, the undersigned agrees that, without the
prior written consent of CSFB, it will not, during the Lock-Up Period, make any
demand for, or exercise any right with respect to, the registration of any
Securities or any security convertible into or exercisable or exchangeable for
the Securities except in connection with the Offering.

     The initial Lock-Up Period will commence on the date of this Lock-Up
Agreement and continue for 180 days after the public offering date set forth on
the final prospectus used to sell the Securities (the “Public Offering Date”)
pursuant to the Underwriting Agreement; provided, however, that if (1) during
the last 17 days of the initial Lock-Up Period, the Company releases earnings
results or material news or a material event relating to the Company occurs
(and, in the case of material news or material event, CSFB gives the notice
thereof to [     ] or (2) prior to the expiration of the initial Lock-Up Period,
the Company announces that it will release earnings results during the 16-day
period beginning on the last day of the initial Lock-Up Period, then in each
case the Lock-Up Period will be extended until the expiration of the 18-day
period beginning on the date of release of the earnings results (which in the
case of clause (2) must occur prior to the

 

--------------------------------------------------------------------------------

 

expiration of such 16-day period) or the occurrence of the material news or
material event, as applicable, unless CSFB waives, in writing, such extension.

     Any Securities received upon exercise of options granted to the undersigned
will also be subject to this Agreement. Any Securities acquired by the
undersigned in the open market or in the issuer directed share program, and any
Securities sold in the Offering pursuant to the Underwriting Agreement, will not
be subject to this Agreement. A transfer of Securities (or other transaction of
the types restricted in the first paragraph of this letter) to a family member,
trust, affiliate of the undersigned, or a director, officer or employee of the
undersigned or of an affiliate of the undersigned may be made, provided the
transferee agrees to be bound in writing by the terms of this Agreement. In
addition, the undersigned may transfer Securities or securities convertible into
or exchangeable or exercisable for Securities pursuant to a sale of 100% of the
outstanding Securities (including, without limitation, in connection with a
tender offer for such Securities or by way of merger of the Company with another
person) to a third party or group of third parties that are not affiliates of
the Company (and may make offers or enter into contracts with respect to such a
transfer), provided that unless the third party or group is acquiring 100% of
the outstanding Securities of the Company in a single transaction or concurrent
transactions, the third party or group of third parties agrees in writing to be
bound by the restrictions set forth herein until such time as such third party
or group of third parties has acquired 100% of the outstanding Securities of the
Company.

     In furtherance of the foregoing, the Company and its transfer agent and
registrar are hereby authorized to decline to make any transfer of shares of
Securities if such transfer would constitute a violation or breach of this
Agreement.

     This Agreement shall be binding on the undersigned and the successors,
heirs, personal representatives and assigns of the undersigned. This Agreement
shall lapse and become null and void (a) if the Underwriting Agreement or the
obligation of the Underwriters to purchase Securities thereunder is terminated,
(b) if the registration statement filed with the SEC in respect of the Offering
is withdrawn, (c) if the closing of the Offering pursuant to the Underwriting
Agreement shall not have occurred on or before October 31, 2004 or (d) if, prior
to the undersigned’s execution and delivery of the Underwriting Agreement, the
undersigned notifies CSFB in writing at its address set forth above (Attention:
Transactions Advisory Group) that it does not then intend to pursue an offering
of the Securities through CSFB as an underwriter. This Agreement shall be
governed by, and construed in accordance with, the laws of the State of New
York.

            Very truly yours,
      By:          

--------------------------------------------------------------------------------

    Name:        

--------------------------------------------------------------------------------